Expert Rev Anticancer Ther. 2009;9(4):511-523. With current standard treatment, including multiagent chemotherapy and surgical resection, 70% of patients with localized osteosarcoma are cured.
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor ...
Osteosarcoma is the bone tumor that most commonly affects children, adolescents, and young adults. Before 1970, treatment primarily included surgical resection. However, the introduction of ...
Osteosarcoma primarily affects long bones in teenagers and young adults, requiring early diagnosis for effective treatment. Treatment strategies vary by stage, with surgery and chemotherapy as primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback